Introduced by Rep. Karen Whitsett (D) on February 24, 2021
To impose new rules, restrictions and disclosure provisions on health insurers and pharmacy benefit managers in selling and marketing prescription drugs to certain hospitals and medical service providers who are eligible for discounts under a federal law. Official Text and Analysis.
Referred to the House Health Policy Committee on February 24, 2021
Reported in the House on March 11, 2021
With the recommendation that the substitute (H-3) be adopted and that the bill then pass.